Concepedia

Thomas Colatsky

TC

Statistics

Publications

40

Citations

4.1K

H-Index

27

Active since

1979

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Princeton University

Women's Health Research Institute

Seabrook

Thomas Colatsky is an author at Center for Drug Evaluation and Research specializing in medicine, physiology, and electrophysiology.

Top concepts

Publications per year

1979–2017

40

Publications

40

Long QT Syndrome Patients With Mutations of the <i>SCN5A</i> and <i>HERG</i> Genes Have Differential Responses to Na <sup>+</sup> Channel Blockade and to Increases in Heart Rate

Peter J. Schwartz, Silvia G. Priori, Emanuela H. Locati et al. · Circulation · 1995 · 812 citations

The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress

Thomas Colatsky, Bernard Fermini, Gary A. Gintant et al. · Journal of Pharmacological and Toxicological Methods · 2016 · 443 citations · Full text

, , +21

Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs

Donna A. Volpe, Anne‐Marie Tobin, R. Daniel Mellon et al. · Regulatory Toxicology and Pharmacology · 2011 · 430 citations

, , +11

Mechanisms of action of lidocaine and quinidine on action potential duration in rabbit cardiac Purkinje fibers. An effect on steady state sodium currents?

Thomas Colatsky · Circulation Research · 1982 · 210 citations · Full text

Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel–Drug Binding Kinetics and Multichannel Pharmacology

Zhihua Li, Sara Dutta, Jiansong Sheng et al. · Circulation Arrhythmia and Electrophysiology · 2017 · 196 citations · Full text

1–5 of 40